Search - tctmd.com

Displaying 561 - 580 of 874

Sort: Relevancy | Date

Presentation TCT 2017

Flash Debate: The Impella Series of Devices Is the Current Gold Standard for Mechanical Support During High-Risk PCI!

Presenter: Navin K. Kapur, Jeffrey W. Moses, Jonathan M. Hill

October 31, 2017

Presentation TCT 2017

Flash Debate: An IABP Is Really All the Circulatory Support a Good Interventionalist Needs for Almost All Cases of High-Risk PCI!

Presenter: Navin K. Kapur, Jeffrey W. Moses, Gert Richardt

October 31, 2017

Presentation TCT 2017

When Should Hemodynamic Support Be Used During PCI?

Presenter: Navin K. Kapur, Jeffrey W. Moses, Francesco Burzotta

October 31, 2017

Presentation TCT 2017

Diagnosis and Treatment Options for RV Shock

Presenter: Vladimir Dzavik, Navin K. Kapur, James A. Goldstein

October 31, 2017

Presentation TCT 2017

Cardiogenic Shock in the Elderly: Rational Treatment Suggestions

Presenter: Vladimir Dzavik, Navin K. Kapur, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

Cardiac Arrest With Cardiogenic Shock: Specific Management Considerations

Presenter: Vladimir Dzavik, Navin K. Kapur, Christian M. Spaulding

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of ECMO

Presenter: Vladimir Dzavik, Navin K. Kapur, Robb Kociol

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of Impella

Presenter: Vladimir Dzavik, Navin K. Kapur, Mark B. Anderson

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of IABP

Presenter: Vladimir Dzavik, Navin K. Kapur, David A Baran

October 31, 2017

Presentation TCT 2017

Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy?

Presenter: Vladimir Dzavik, Navin K. Kapur, Nicolas M. Van Mieghem

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: Pathophysiology, Hemodynamics, and Treatment Goals

Presenter: Vladimir Dzavik, Navin K. Kapur, Holger Thiele

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

Classifying Aortic Stenosis According to Pathophysiology and Hemodynamics An Echocardiographers Perspective

Presenter: Philippe Pibarot

October 30, 2017

Presentation TCT 2017

The Hemodynamics of Diastology, LVOT Obstruction, and Exercise Physiology in HCM

Presenter: Morton J. Kern, Sherif F. Nagueh

October 30, 2017

Presentation TCT 2017

Hemodynamics of Right Heart Pressures

Presenter: Jeff Davis, Scott Lim

October 29, 2017

Presentation TCT 2017

Hemodynamics of Mitral Regurgitation

Presenter: Jeff Davis, Perwaiz M. Meraj

October 29, 2017

Presentation TCT 2017

Hemodynamics of Aortic Stenosis

Presenter: Thomas H. Maloney, Jeff Davis

October 29, 2017

News Daily News

Atrial Fibrillation in Obese Patients a Growing Concern, Experts Say

Caitlin E. Cox

October 10, 2017

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

News Daily News

FDA Grants HeartWare LVAD a Destination Therapy Indication

Todd Neale

September 28, 2017

Advertisement

Flash Debate: The Impella Series of Devices Is the Current Gold Standard for Mechanical Support During High-Risk PCI!

Flash Debate: An IABP Is Really All the Circulatory Support a Good Interventionalist Needs for Almost All Cases of High-Risk PCI!

When Should Hemodynamic Support Be Used During PCI?

Diagnosis and Treatment Options for RV Shock

Cardiogenic Shock in the Elderly: Rational Treatment Suggestions

Cardiac Arrest With Cardiogenic Shock: Specific Management Considerations

Acute Cardiogenic Shock: The Case for First-line Use of ECMO

Acute Cardiogenic Shock: The Case for First-line Use of Impella

Acute Cardiogenic Shock: The Case for First-line Use of IABP

Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy?

Acute Cardiogenic Shock: Pathophysiology, Hemodynamics, and Treatment Goals

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Classifying Aortic Stenosis According to Pathophysiology and Hemodynamics An Echocardiographers Perspective

The Hemodynamics of Diastology, LVOT Obstruction, and Exercise Physiology in HCM

Hemodynamics of Right Heart Pressures

Hemodynamics of Mitral Regurgitation

Hemodynamics of Aortic Stenosis

Atrial Fibrillation in Obese Patients a Growing Concern, Experts Say

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

FDA Grants HeartWare LVAD a Destination Therapy Indication

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content